Takayuki Kosaka
- Pulmonary and Respiratory Medicine top 0.1%
- Oncology top 0.2%
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Tetsuya MitsudomiYasushi YatabeHiroyuki KuwanoTakashi TakahashiHideki EndohPasi A. JänneBruce E. JohnsonToyoaki Hida
- Topics
- Lung Cancer Treatments and Mutations (49 papers)Lung Cancer Diagnosis and Treatment (20 papers)Colorectal Cancer Treatments and Studies (14 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Takayuki Kosaka
88 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Pulmonary and Respiratory Medicine 6.5k
- Oncology 5.6k
- Molecular Biology 3.8k
- Cancer Research 1.8k
- Pathology and Forensic Medicine 726
Countries citing papers authored by Takayuki Kosaka
This map shows the geographic impact of Takayuki Kosaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayuki Kosaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayuki Kosaka more than expected).
Fields of papers citing papers by Takayuki Kosaka
This network shows the impact of papers produced by Takayuki Kosaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayuki Kosaka. The network helps show where Takayuki Kosaka may publish in the future.
Co-authorship network of co-authors of Takayuki Kosaka
This figure shows the co-authorship network connecting the top 25 collaborators of Takayuki Kosaka. A scholar is included among the top collaborators of Takayuki Kosaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takayuki Kosaka. Takayuki Kosaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 29 | |
| 5 | 6 | |
| 6 | 8 | |
| 7 | 100 | |
| 8 | 10 | |
| 9 | 67 | |
| 10 | 0 | |
| 11 | 47 | |
| 12 | 5 | |
| 13 | 196 | |
| 14 | 247 | |
| 15 | 30 | |
| 16 | MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signalingbreakdown → | 3570 |
| 17 | 165 | |
| 18 | 2 | |
| 19 | 45 | |
| 20 | 1 |
About Takayuki Kosaka
Takayuki Kosaka is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Neurology, having authored 93 papers that have together received 9.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (49 papers), Lung Cancer Diagnosis and Treatment (20 papers) and Colorectal Cancer Treatments and Studies (14 papers). The work is most often cited by research in Oncology (5.6k citations), Pulmonary and Respiratory Medicine (6.5k citations) and Cancer Research (1.8k citations). Takayuki Kosaka has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Tetsuya Mitsudomi, Yasushi Yatabe, Hiroyuki Kuwano, Takashi Takahashi, Hideki Endoh, Pasi A. Jänne, Bruce E. Johnson, Toyoaki Hida, Charles Lee and Youngchul Song. Their work appears in journals such as Science, Angewandte Chemie International Edition and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.